These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6413485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.
    Masuyoshi S, Inoue M, Takaoka M, Mitsuhashi S.
    Arzneimittelforschung; 1981; 31(7):1070-2. PubMed ID: 6268122
    [Abstract] [Full Text] [Related]

  • 4. Affinity of cefoperazone for penicillin-binding proteins.
    Matsubara N, Minami S, Matsuhashi M, Takaoka M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Jul; 18(1):195-9. PubMed ID: 6448021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.
    Pucci MJ, Boice-Sowek J, Kessler RE, Dougherty TJ.
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2312-7. PubMed ID: 1804003
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial and pharmacokinetic properties of M14659, a new injectable semisynthetic cephalosporin.
    Mochizuki H, Oikawa Y, Yamada H, Kusakabe S, Shiihara T, Murakami K, Kato K, Ishiguro J, Kosuzume H.
    J Antibiot (Tokyo); 1988 Mar; 41(3):377-91. PubMed ID: 3130365
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
    Hashizume T, Nakamura K, Nakagawa S.
    J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of penicillin-binding protein 2 of Staphylococcus aureus: deacylation reaction and identification of two penicillin-binding peptides.
    Chambers HF, Miick C.
    Antimicrob Agents Chemother; 1992 Mar; 36(3):656-61. PubMed ID: 1622180
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
    Tsuchimori N, Okonogi K.
    J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
    [Abstract] [Full Text] [Related]

  • 19. Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins.
    Labia R, Baron P, Masson JM.
    J Antimicrob Chemother; 1985 Jan; 15(1):9-15. PubMed ID: 3918982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.